Categories: News

HealthRecon Connect Successfully Completes SOC 1® Type 2 Examination

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DALLAS, May 27, 2022 (GLOBE NEWSWIRE) — HealthRecon Connect, leading technology enabled revenue cycle management solutions provider to US Healthcare Providers, reaffirmed its commitment to internal security controls by successfully completing the System and Organizational Controls SOC 1® Type 2 examination. The report independently audited by Stakes CPA, LLC, validates that HealthRecon’s infrastructure, general control system, suitability of the design and operating effectiveness of its controls for the period as meeting and/or exceeding the SOC 1® Type 2 criteria as of July 1, 2021 to December 31, 2021.

A widely recognized auditing standard developed by the American Institute of Certified Public Accountants (AICPA), SOC 1 Type 2 examines internal and related external controls pertaining to financial statements – including financial reporting, transactions, security, availability, and processing integrity.

The successful completion of the SOC 1® Type 2 examination complements the organization’s recent achievement of completion of SOC 1® Type 1 examination, awarding of ISO 9001:2015 (Quality Management Systems), ISO 27001:2013 (Information Security Management) and ISO 27701:2019 (Privacy Information Management Systems) certifications and the seal of Compliance from the Compliancy Group, the recognized third-party HIPAA compliance verification standard for healthcare professionals, vendors, and IT professionals across the healthcare industry.

About HealthRecon Connect

HealthRecon Connect LLC provides technology-enabled Revenue Cycle Management solutions to US healthcare providers. The company leverages over 30 years of deep domain expertise, machine learning, AI, cutting-edge analytics, and automated workflows that help improve cash flow, patient outcomes and enable peace of mind for their clients.

For more information, visit www.healthreconconnect.com

Media Contact:
Varun Chandramohan
comms@healthreconconnect.com
www.healthreconconnect.com

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

12 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

12 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

15 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

15 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

15 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

18 hours ago